首页> 外文期刊>The Journal of Urology >Re: Prognostic Utility of Biopsy-Derived Cell Cycle Progression Score in Patients with National Comprehensive Cancer Network Low-Risk Prostate Cancer Undergoing Radical Prostatectomy: Implications for Treatment Guidance

【24h】

Re: Prognostic Utility of Biopsy-Derived Cell Cycle Progression Score in Patients with National Comprehensive Cancer Network Low-Risk Prostate Cancer Undergoing Radical Prostatectomy: Implications for Treatment Guidance

机译：Re：全国综合癌症网络低风险前列腺癌患者进行激进前列腺切除术的患者的活检衍生细胞周期进展的预后效用：对治疗指导的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2017年第5期|共1页
作者
Taneja Samir S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Prognostic Utility of Biopsy-Derived Cell Cycle Progression Score in Patients with National Comprehensive Cancer Network Low-Risk Prostate Cancer Undergoing Radical Prostatectomy: Implications for Treatment Guidance [J] . Taneja Samir S. The Journal of Urology . 2017,第5期

机译：Re：全国综合癌症网络低风险前列腺癌患者进行激进前列腺切除术的患者的活检衍生细胞周期进展的预后效用：对治疗指导的影响
2. Pathologic and Prognostic Outcomes of Very Low- and Low-Risk Prostate Cancer According to the National Comprehensive Cancer Network Guidelines in Japanese Patients with Radical Prostatectomy [J] . Issei Takizawa, Makoto Ohori, Yoshio Ohno, Journal of Cancer Therapy . 2016,第4期

机译：根据国家综合癌症网络指南，日本根治性前列腺切除术患者的极低和低风险前列腺癌的病理和预后结果
3. Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy [J] . Journal of Cancer Research and Clinical Oncology . 2020,第3期

机译：细胞周期进展评分提高了前列腺前列腺切除术后前列腺癌患者的风险分层
4. Changes of the total antioxidative status of blood cells in the progression of stomach and large bowel cancers in patients subjected to primary radical treatment [C] . Z. Kopanski, J. Bertrandt, M. Grabowska, International Conference on Food Factors . 2004

机译：患者初级自由基治疗中胃癌和大肠癌进展中血细胞总抗氧化状态的变化
5. Use of Serum Prostate Specific Antigen Doubling Time and Change to Determine Need for Secondary Treatment for Prostate Cancer following Radical Prostatectomy [D] . Huang, Erica Jayee. 2021

机译：使用血清前列腺特异性抗原的倍增时间和变化，以确定自由基前列腺切除术后前列腺癌的继发性治疗
6. National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence after radical prostatectomy: a retrospective cohort study in Chinese prostate cancer patients [O] . Hua Xu, Yao Zhu, Bo Dai, 2018

机译：美国国家综合癌症网络（NCCN）风险分类预测前列腺癌根治术后生化复发的回顾性队列研究
7. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score is a Novel Significant Prognostic Factor for Patients with Metastatic Prostate Cancer Undergoing Cytoreductive Radical Prostatectomy [O] . Yadong Guo, Donghui Shi, Junfeng Zhang, 2019

机译：血红蛋白，白蛋白，淋巴细胞和血小板（HALP）评分是患有细胞导致自由基前列腺切除术的转移前列腺癌患者的重要预后因素

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号